TEISHIMA, J., KOBATAKE, K., HAYASHI, T., SENO, Y., IKEDA, K., NAGAMATSU, H., . . . MATSUBARA, A. (2014). Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy. D.A. Spandidos.
Chicago-стиль цитированияTEISHIMA, JUN, et al. Prognostic Significance of C-reactive Protein in Patients With Intermediate-risk Metastatic Renal Cell Carcinoma Treated With Molecular Targeted Therapy. D.A. Spandidos, 2014.
MLA-цитированиеTEISHIMA, JUN, et al. Prognostic Significance of C-reactive Protein in Patients With Intermediate-risk Metastatic Renal Cell Carcinoma Treated With Molecular Targeted Therapy. D.A. Spandidos, 2014.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.